ARTICLE - Celebrex's patent expires in November 2014 in Canada

[Guest guest]

Pfizer Wins Celebrex Patent Decision in Canadian Court, Launch of

Generic Product by Novopharm...

Publication: Business Wire

Date: Monday, April 30 2007

NEW YORK -- Pfizer Inc reported today that the Federal Court of Appeal

of Canada has reversed a lower court ruling that would have permitted

generic manufacturer Novopharm to launch a competitor product to

Celebrex. The appellate court issued an order prohibiting regulatory

approval of Novopharm's product in Canada until Celebrex's compound

patent expires in November 2014.

" Today's ruling is an important one not only for Pfizer, but also for

patients in Canada and elsewhere, " said Pfizer General Counsel

Waxman. " Without appropriate protection of intellectual property,

Pfizer and other research-based pharmaceutical companies would not be

able to make the tremendous investments required to develop new,

life-saving medicines that are so critical to public health. "

Novopharm may seek to appeal the decision to the Supreme Court of Canada.

http://www.allbusiness.com/services/business-services/4326725-1.html

Not an MD